CBT and the Neural Circuits of Anxiety

Last updated: February 19, 2025
Sponsor: UCLH/UCL Joint Research Office
Overall Status: Active - Recruiting

Phase

N/A

Condition

Depression

Anxiety Disorders

Panic Disorders

Treatment

Cognitive Behavioural Therapy

Waiting List

Clinical Study ID

NCT05549102
121261
255501
  • Ages 18-64
  • All Genders

Study Summary

This study will aim to test whether specific neural circuitry changes, proposed on the basis of a neurocognitive model of anxiety, are a mechanism of action for Cognitive Behavioural Therapy (CBT) interventions. This study aims to provide a theoretical model of the neurobiological mechanisms of CBT's therapeutic effect, where there currently is none, and potentially allow for more targeted/specific approaches to anxiety disorders following the identification of key CBT mechanisms. The ultimate aim is to improve the efficacy of CBT, and more generally, psychological interventions for anxiety disorders.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Enrolled in IAPT Step 3 (high intensity service)

  • Score of or above 8 on the GAD-7 (indicating moderate anxiety on a standard scale ofanxiety; Spitzer et al., 2006)

  • Willing and able to provide written consent

Exclusion

Exclusion Criteria:

  • Score above 22 on the GAD-7

  • Past/present psychotic disorder, bipolar disorder/mania or alcohol/substance usedisorder (outside a comorbid psychiatric episode)

  • History of medical illness that may impair cognitive function (e.g. serious headinjury, endocrine disorder)

  • Current psychotropic pharmacological intervention (e.g. SSRIs) or use within 3months

  • MRI contraindications such as pacemaker, aneurysm clip, cochlear implant,neurostimulator, IUD, shrapnel, metal fragments in eye, weight of above 250lbs orclaustrophobia

  • Females who are pregnant, planning pregnancy, or breastfeeding

Study Design

Total Participants: 174
Treatment Group(s): 2
Primary Treatment: Cognitive Behavioural Therapy
Phase:
Study Start date:
February 02, 2020
Estimated Completion Date:
April 01, 2025

Study Description

To test the hypothesis that the neural circuitry of the amygdala and prefrontal cortex will respond to CBT, the impact of a course of CBT on cortical-subcortical circuitry will be tested via a case-control study in individuals entering Improving Access to Psychological Therapies (IAPT) services (IAPT step 3; i.e., full CBT) for anxiety disorders and individuals in waiting lists. This design leverages the naturalistic waiting times in the clinical service and does not interfere with treatment as usual. Measures of brain region-specific connectivity and emotion-related behavioural performance will be assessed through testing sessions at the University College London (UCL) Institute of Cognitive Neuroscience and the Birkbeck-UCL Centre for NeuroImaging (BUCNI), involving computerised cognitive/psychological tasks and functional magnetic resonance imaging (fMRI).

The aims are to:

  1. test whether this circuit responds to a course of CBT, by demonstrating disengagement of the circuit following CBT

  2. relate this change in circuit function to behaviour through cognitive measures of emotional processing

  3. explore the neurobiological features that distinguish patients who respond to CBT and those who do not

  4. compare the data from this study to another on-going study assessing the impact of pharmacological interventions for anxiety, allowing for the comparison of neurobiological mechanisms of psychological vs. pharmacological treatments in anxiety.

Connect with a study center

  • Institute of Cognitive Neuroscience, University College London

    London, WC1N 3AZ
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.